CSCO vs. JNJ: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at CSCO and JNJ, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | CSCO | JNJ |
|---|---|---|
| Company Name | Cisco Systems, Inc. | Johnson & Johnson |
| Country | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry | Communications Equipment | Pharmaceuticals |
| Market Capitalization | 284.09 billion USD | 453.94 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | February 16, 1990 | January 2, 1962 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of CSCO and JNJ by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | CSCO | JNJ |
|---|---|---|
| 5-Day Price Return | -0.32% | 0.83% |
| 13-Week Price Return | 2.01% | 8.39% |
| 26-Week Price Return | 21.02% | 19.78% |
| 52-Week Price Return | 24.12% | 20.21% |
| Month-to-Date Return | -1.40% | -0.24% |
| Year-to-Date Return | 21.77% | 30.28% |
| 10-Day Avg. Volume | 19.58M | 7.36M |
| 3-Month Avg. Volume | 18.90M | 8.42M |
| 3-Month Volatility | 20.61% | 12.42% |
| Beta | 0.87 | 0.34 |
Profitability
Return on Equity (TTM)
CSCO
22.18%
Communications Equipment Industry
- Max
- 32.30%
- Q3
- 20.90%
- Median
- 9.10%
- Q1
- 4.29%
- Min
- -13.50%
In the upper quartile for the Communications Equipment industry, CSCO’s Return on Equity of 22.18% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
JNJ
32.69%
Pharmaceuticals Industry
- Max
- 38.59%
- Q3
- 19.84%
- Median
- 11.85%
- Q1
- 5.40%
- Min
- -10.91%
In the upper quartile for the Pharmaceuticals industry, JNJ’s Return on Equity of 32.69% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
Net Profit Margin (TTM)
CSCO
17.97%
Communications Equipment Industry
- Max
- 23.65%
- Q3
- 12.56%
- Median
- 5.62%
- Q1
- 2.50%
- Min
- -3.09%
A Net Profit Margin of 17.97% places CSCO in the upper quartile for the Communications Equipment industry, signifying strong profitability and more effective cost management than most of its peers.
JNJ
27.26%
Pharmaceuticals Industry
- Max
- 40.67%
- Q3
- 19.07%
- Median
- 12.31%
- Q1
- 4.50%
- Min
- -9.91%
A Net Profit Margin of 27.26% places JNJ in the upper quartile for the Pharmaceuticals industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin (TTM)
CSCO
20.76%
Communications Equipment Industry
- Max
- 25.23%
- Q3
- 13.72%
- Median
- 6.44%
- Q1
- 3.00%
- Min
- -10.95%
An Operating Profit Margin of 20.76% places CSCO in the upper quartile for the Communications Equipment industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
JNJ
34.19%
Pharmaceuticals Industry
- Max
- 45.78%
- Q3
- 23.14%
- Median
- 16.68%
- Q1
- 7.98%
- Min
- -7.13%
An Operating Profit Margin of 34.19% places JNJ in the upper quartile for the Pharmaceuticals industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | CSCO | JNJ |
|---|---|---|
| Return on Equity (TTM) | 22.18% | 32.69% |
| Return on Assets (TTM) | 8.37% | 13.22% |
| Net Profit Margin (TTM) | 17.97% | 27.26% |
| Operating Profit Margin (TTM) | 20.76% | 34.19% |
| Gross Profit Margin (TTM) | 64.94% | 68.14% |
Financial Strength
Current Ratio (MRQ)
CSCO
1.00
Communications Equipment Industry
- Max
- 3.33
- Q3
- 2.13
- Median
- 1.55
- Q1
- 1.15
- Min
- 0.91
CSCO’s Current Ratio of 1.00 falls into the lower quartile for the Communications Equipment industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
JNJ
1.07
Pharmaceuticals Industry
- Max
- 4.65
- Q3
- 2.64
- Median
- 1.85
- Q1
- 1.26
- Min
- 0.78
JNJ’s Current Ratio of 1.07 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
CSCO
0.60
Communications Equipment Industry
- Max
- 1.44
- Q3
- 0.86
- Median
- 0.53
- Q1
- 0.22
- Min
- 0.00
CSCO’s Debt-to-Equity Ratio of 0.60 is typical for the Communications Equipment industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
JNJ
0.58
Pharmaceuticals Industry
- Max
- 1.75
- Q3
- 0.82
- Median
- 0.35
- Q1
- 0.13
- Min
- 0.00
JNJ’s Debt-to-Equity Ratio of 0.58 is typical for the Pharmaceuticals industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
CSCO
22.76
Communications Equipment Industry
- Max
- 55.49
- Q3
- 34.19
- Median
- 7.59
- Q1
- 3.73
- Min
- -9.94
CSCO’s Interest Coverage Ratio of 22.76 is positioned comfortably within the norm for the Communications Equipment industry, indicating a standard and healthy capacity to cover its interest payments.
JNJ
34.01
Pharmaceuticals Industry
- Max
- 103.95
- Q3
- 43.60
- Median
- 9.83
- Q1
- 2.37
- Min
- -42.71
JNJ’s Interest Coverage Ratio of 34.01 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | CSCO | JNJ |
|---|---|---|
| Current Ratio (MRQ) | 1.00 | 1.07 |
| Quick Ratio (MRQ) | 0.91 | 0.71 |
| Debt-to-Equity Ratio (MRQ) | 0.60 | 0.58 |
| Interest Coverage Ratio (TTM) | 22.76 | 34.01 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
CSCO
2.26%
Communications Equipment Industry
- Max
- 8.13%
- Q3
- 3.29%
- Median
- 0.94%
- Q1
- 0.00%
- Min
- 0.00%
CSCO’s Dividend Yield of 2.26% is consistent with its peers in the Communications Equipment industry, providing a dividend return that is standard for its sector.
JNJ
2.72%
Pharmaceuticals Industry
- Max
- 7.14%
- Q3
- 3.45%
- Median
- 2.17%
- Q1
- 0.33%
- Min
- 0.00%
JNJ’s Dividend Yield of 2.72% is consistent with its peers in the Pharmaceuticals industry, providing a dividend return that is standard for its sector.
Dividend Payout Ratio (TTM)
CSCO
63.23%
Communications Equipment Industry
- Max
- 111.16%
- Q3
- 70.91%
- Median
- 30.78%
- Q1
- 0.00%
- Min
- 0.00%
CSCO’s Dividend Payout Ratio of 63.23% is within the typical range for the Communications Equipment industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
JNJ
48.70%
Pharmaceuticals Industry
- Max
- 199.58%
- Q3
- 97.17%
- Median
- 53.47%
- Q1
- 22.97%
- Min
- 0.00%
JNJ’s Dividend Payout Ratio of 48.70% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | CSCO | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 2.26% | 2.72% |
| Dividend Payout Ratio (TTM) | 63.23% | 48.70% |
Valuation
Price-to-Earnings Ratio (TTM)
CSCO
27.99
Communications Equipment Industry
- Max
- 103.74
- Q3
- 61.65
- Median
- 26.20
- Q1
- 18.12
- Min
- 4.19
CSCO’s P/E Ratio of 27.99 is within the middle range for the Communications Equipment industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
JNJ
17.91
Pharmaceuticals Industry
- Max
- 45.19
- Q3
- 27.91
- Median
- 20.59
- Q1
- 15.08
- Min
- 3.79
JNJ’s P/E Ratio of 17.91 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
CSCO
5.03
Communications Equipment Industry
- Max
- 6.86
- Q3
- 6.24
- Median
- 2.44
- Q1
- 1.02
- Min
- 0.48
CSCO’s P/S Ratio of 5.03 aligns with the market consensus for the Communications Equipment industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
JNJ
4.88
Pharmaceuticals Industry
- Max
- 8.87
- Q3
- 4.56
- Median
- 2.14
- Q1
- 1.58
- Min
- 0.11
JNJ’s P/S Ratio of 4.88 is in the upper echelon for the Pharmaceuticals industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
Price-to-Book Ratio (MRQ)
CSCO
5.74
Communications Equipment Industry
- Max
- 6.28
- Q3
- 5.73
- Median
- 3.32
- Q1
- 2.02
- Min
- 0.42
CSCO’s P/B Ratio of 5.74 is in the upper tier for the Communications Equipment industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
JNJ
5.52
Pharmaceuticals Industry
- Max
- 9.78
- Q3
- 4.99
- Median
- 2.48
- Q1
- 1.53
- Min
- 0.59
JNJ’s P/B Ratio of 5.52 is in the upper tier for the Pharmaceuticals industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
Valuation at a Glance
| Symbol | CSCO | JNJ |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 27.99 | 17.91 |
| Price-to-Sales Ratio (TTM) | 5.03 | 4.88 |
| Price-to-Book Ratio (MRQ) | 5.74 | 5.52 |
| Price-to-Free Cash Flow Ratio (TTM) | 21.45 | 22.96 |